What is C4 Therapeutics, Inc.'s Market Cap?

C4 Therapeutics, Inc.'s Market Cap is $436.7M, based on as-reported figures from SEC (XBRL) filings.

What is C4 Therapeutics, Inc.'s Price / Sales?

C4 Therapeutics, Inc.'s Price / Sales is 12.5×, based on as-reported figures from SEC (XBRL) filings.

What is C4 Therapeutics, Inc.'s Revenue (TTM)?

C4 Therapeutics, Inc.'s Revenue (TTM) is $35.0M, based on as-reported figures from SEC (XBRL) filings.

What is C4 Therapeutics, Inc.'s Net Income (TTM)?

C4 Therapeutics, Inc.'s Net Income (TTM) is -$101.4M, based on as-reported figures from SEC (XBRL) filings.

What is C4 Therapeutics, Inc.'s EBITDA?

C4 Therapeutics, Inc.'s EBITDA is -$109.8M, based on as-reported figures from SEC (XBRL) filings.

What is C4 Therapeutics, Inc.'s Diluted EPS (TTM)?

C4 Therapeutics, Inc.'s Diluted EPS (TTM) is -0.82, based on as-reported figures from SEC (XBRL) filings.

What is C4 Therapeutics, Inc.'s EBITDA Margin?

C4 Therapeutics, Inc.'s EBITDA Margin is -313.4%, based on as-reported figures from SEC (XBRL) filings.

C4 Therapeutics, Inc. (CCCC) Financial Statements

C4 Therapeutics, Inc.

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00BV2Y9C6

XNAS · usd

3.55▼ 0.21 (-5.59%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close3.76

Day's Range3.55 – 3.74

52-Week Range1.69 – 5.17

Volume2.2M

Avg Volume2.3M

Share Statistics

Shares Outstanding

Employees104

ExchangeXNAS

Listed2020-10-02

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about C4 Therapeutics, Inc. (CCCC)

What is C4 Therapeutics, Inc.'s Market Cap?: C4 Therapeutics, Inc.'s Market Cap is $436.7M, based on as-reported figures from SEC (XBRL) filings.
What is C4 Therapeutics, Inc.'s Price / Sales?: C4 Therapeutics, Inc.'s Price / Sales is 12.5×, based on as-reported figures from SEC (XBRL) filings.
What is C4 Therapeutics, Inc.'s Revenue (TTM)?: C4 Therapeutics, Inc.'s Revenue (TTM) is $35.0M, based on as-reported figures from SEC (XBRL) filings.
What is C4 Therapeutics, Inc.'s Net Income (TTM)?: C4 Therapeutics, Inc.'s Net Income (TTM) is -$101.4M, based on as-reported figures from SEC (XBRL) filings.
What is C4 Therapeutics, Inc.'s EBITDA?: C4 Therapeutics, Inc.'s EBITDA is -$109.8M, based on as-reported figures from SEC (XBRL) filings.
What is C4 Therapeutics, Inc.'s Diluted EPS (TTM)?: C4 Therapeutics, Inc.'s Diluted EPS (TTM) is -0.82, based on as-reported figures from SEC (XBRL) filings.
What is C4 Therapeutics, Inc.'s EBITDA Margin?: C4 Therapeutics, Inc.'s EBITDA Margin is -313.4%, based on as-reported figures from SEC (XBRL) filings.